Corrigendum: Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018)

J. A. Kulas, W. F. Franklin, N. A. Smith, G. D. Manocha, K. L. Puig, K. Nagamoto-Combs, R. D. Hendrix, Giulio Taglialatela, S. W. Barger, C. K. Combs

Research output: Contribution to journalComment/debate

Abstract

Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. Am J Physiol Endocrinol Metab 316: E106–E120, 2019. First published November 13, 2018; doi:10.1152/ajpendo.00279.2018.—In DISCLOSURES, the following statement was omitted in error: “S. W. Barger receives royalties from Merck/Sigma-Aldrich for the sales of secreted amyloid precursor protein.”

Original languageEnglish (US)
Pages (from-to)E345
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume316
Issue number2
DOIs
StatePublished - Feb 1 2019
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)

Cite this